Product Description
Publication Date: April 12, 2011
Industry: Pharmaceutical industry
Source: Harvard Business School
Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.
Product #:
Pages:
25
Related Topics:
